The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation

Medical Hypotheses

Volumn 69, Issue 3, 2007, Pages 517-525

  Katz, David L ^a,b   Greene, Lindsey ^a   Ali, Ather ^a,b   Faridi, Zubaida ^a  

^a Yale Griffin Prevention Research Center   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIOXIDANT; CORTICOSTEROID; DOPAMINE RECEPTOR STIMULATING AGENT; MAGNESIUM; NONSTEROID ANTIINFLAMMATORY AGENT; SEDATIVE AGENT; TRACE ELEMENT; TRICYCLIC ANTIDEPRESSANT AGENT; VASODILATOR AGENT;

ALTERNATIVE MEDICINE; ARTICLE; FIBROMYALGIA; HUMAN; HYPOTHESIS; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MUSCLE HYPOPERFUSION; MUSCLE PERFUSION; MYALGIA; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; VASOCONSTRICTION;

AUTOIMMUNITY; FIBROMYALGIA; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; MUSCLES; NITRIC OXIDE; PAIN; PERFUSION; RECURRENCE; VASOMOTOR SYSTEM;

EID: 34447286017     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.10.037     Document Type: Article

References (106)

1. Wolfe F., et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 2 (1990) 160-172
2. Gracely R.H., Grant M.A., and Giesecke T. Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 17 4 (2003) 593-609
3. Rao S.G., and Clauw D.J. The management of fibromyalgia. Drugs Today (Barc) 40 6 (2004) 539-554
4. Fietta P. Fibromyalgia: state of the art. Minerva Med 95 1 (2004) 35-47 47-52
5. Wolfe F., et al. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 24 3 (1997) 555-559
6. Lawrence R.C., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41 5 (1998) 778-799
7. Felson D.T. Epidemiology of the rheumatic diseases. In: Koopman W.J. (Ed). Arthritis and allied conditions. 14th ed. (2001), Lippincott Williams & Wilkins, Philadelphia (PA) 3-38
8. White K.P., and Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep 5 4 (2001) 320-329
9. Gran J.T. The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17 4 (2003) 547-561
10. Marder W.D., et al. The present and future adequacy of rheumatology manpower. A study of health care needs and physician supply. Arthritis Rheum 34 10 (1991) 1209-1217
11. Yunus M.B. Gender differences in fibromyalgia and other related syndromes. J Gend Specif Med 5 2 (2002) 42-47
12. Buskila D., et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol 20 2 (1993) 368-370
13. Clark P., et al. Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol 25 10 (1998) 2009-2014
14. Yunus M.B. Genetic factors in fibromyalgia syndrome. Z Rheumatol 57 Suppl. 2 (1998) 61-62
15. Jacobsson L.T., et al. Low prevalences of chronic widespread pain and shoulder disorders among the Pima Indians. J Rheumatol 23 5 (1996) 907-909
16. Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand J Rheumatol Suppl 113 (2000) 8-12
17. Neeck G., and Riedel W. Neuromediator and hormonal perturbations in fibromyalgia syndrome: results of chronic stress?. Baillieres Clin Rheumatol 8 4 (1994) 763-775
18. Okifuji A., and Turk D.C. Stress and psychophysiological dysregulation in patients with fibromyalgia syndrome. Appl Psychophysiol Biofeedback 27 2 (2002) 129-141
19. Garrison R.L., and Breeding P.C. A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses 61 2 (2003) 182-189
20. Arthritis Foundation. Delivering on the Promise in Fibromyalgia. 2004 [cited; Available from: http://www.arthritis.org/research/research_program/Fibromyalgia/default.asp.
21. Pillemer S.R., et al. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 40 11 (1997) 1928-1939
22. Bennett R. Fibromyalgia: present to future. Curr Pain Headache Rep 8 5 (2004) 379-384
23. Inanici F., and Yunus M.B. History of fibromyalgia: past to present. Curr Pain Headache Rep 8 5 (2004) 369-378
24. Yunus M.B. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 19 6 (1992) 846-850
25. Daoud K.F., and Barkhuizen A. Rheumatic mimics and selected triggers of fibromyalgia. Curr Pain Headache Rep 6 4 (2002) 284-288
26. Kerschbaumer A., et al. Fibromyalgia may mask onset of autoimmune diseases. Eur J Pain 7 3 (2003) 295-296
27. Staines D.R. Is fibromyalgia an autoimmune disorder of endogenous vasoactive neuropeptides?. Med Hypotheses 62 5 (2004) 665-669
28. Bagis S., et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?. Rheumatol Int 25 3 (2005) 188-190
29. Sackner M.A., Gummels E.M., and Adams J.A. Say NO to fibromyalgia and chronic fatigue syndrome: an alternative and complementary therapy to aerobic exercise. Med Hypotheses 63 1 (2004) 118-123
30. Bennett R. Fibromyalgia. In: Wall, and Melzack (Eds). Textbook of pain (1999), Churchill Livingstone, Inc 585
31. Bengtsson A. The muscle in fibromyalgia. Rheumatology (Oxford) 41 7 (2002) 721-724
32. Guyton A., and Hall J. Textbook of medical physiology. 10th ed. (2000), W B Saunders Co
33. Mayo Clinic staff. How you feel pain. 2005 [cited; Available from: http://www.mayoclinic.com/invoke.cfm?id=PN00017.
34. Bruckle W., and Zeidler H. Fibromyalgia - An update. Internist (Berl) (2005)
35. Schaible H.G., and Vanegas H. How do we manage chronic pain?. Baillieres Best Pract Res Clin Rheumatol 14 4 (2000) 797-811
36. Wall, Melzack, editors. Muscles, tendons, and ligaments. Textbook of pain. Churchill Livingstone, Inc, 1999. p. 585.
37. Lawson K. Tricyclic antidepressants and fibromyalgia: what is the mechanism of action?. Expert Opin Investig Drugs 11 10 (2002) 1437-1445
38. Rao S.G., and Bennett R.M. Pharmacological therapies in fibromyalgia. Best Pract Res Clin Rheumatol 17 4 (2003) 611-627
39. Wolfe F., et al. Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40 9 (1997) 1571-1579
40. Mannerkorpi K. Exercise in fibromyalgia. Curr Opin Rheumatol 17 2 (2005) 190-194
41. Yildiz S., et al. A new treatment modality for fibromyalgia syndrome: hyperbaric oxygen therapy. J Int Med Res 32 3 (2004) 263-267
42. Hong C.Z., and Hsueh T.C. Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia. Arch Phys Med Rehabil 77 11 (1996) 1161-1166
43. Bradley L., and Alarcon G. Fibromyalgia. In: WJ K. (Ed). Arthritis and allied conditions (1997), Williams & Wilkins, Baltimore 3-34
44. Singh B.B., et al. A pilot study of cognitive behavioral therapy in fibromyalgia. Altern Ther Health Med 4 2 (1998) 67-70
45. Mason L.W., Goolkasian P., and McCain G.A. Evaluation of multimodal treatment program for fibromyalgia. J Behav Med 21 2 (1998) 163-178
46. Bennett R.M. Beyond fibromyalgia: ideas on etiology and treatment. J Rheumatol Suppl 19 (1989) 185-191
47. Clark S.R. Prescribing exercise for fibromyalgia patients. Arthritis Care Res 7 4 (1994) 221-225
48. Buckelew S.P., et al. Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial. Arthritis Care Res 11 3 (1998) 196-209
49. Drexler A.R., Mur E.J., and Gunther V.C. Efficacy of an EMG-biofeedback therapy in fibromyalgia patients. A comparative study of patients with and without abnormality in (MMPI) psychological scales. Clin Exp Rheumatol 20 5 (2002) 677-682
50. King S.J., et al. The effects of exercise and education, individually or combined, in women with fibromyalgia. J Rheumatol 29 12 (2002) 2620-2627
51. Wahner-Roedler D.L., et al. Use of complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program at a tertiary care center. Mayo Clin Proc 80 1 (2005) 55-60
52. Holdcraft L.C., Assefi N., and Buchwald D. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 17 4 (2003) 667-683
53. Merchant R.E., Carmack C.A., and Wise C.M. Nutritional supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study. Phytother Res 14 3 (2000) 167-173
54. Merchant R.E., and Andre C.A. A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. Altern Ther Health Med 7 3 (2001) 79-91
55. Taggart H.M., et al. Effects of T'ai Chi exercise on fibromyalgia symptoms and health-related quality of life. Orthop Nurs 22 5 (2003) 353-360
56. Astin J.A., et al. The efficacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: a randomized controlled trial. J Rheumatol 30 10 (2003) 2257-2262
57. Dimmock S., Troughton P.R., and Bird H.A. Factors predisposing to the resort of complementary therapies in patients with fibromyalgia. Clin Rheumatol 15 5 (1996) 478-482
58. Hadhazy V.A., et al. Mind-body therapies for the treatment of fibromyalgia. A systematic review. J Rheumatol 27 12 (2000) 2911-2918
59. Crofford L.J., and Appleton B.E. Complementary and alternative therapies for fibromyalgia. Curr Rheumatol Rep 3 2 (2001) 147-156
60. Berman B.M., and Swyers J.P. Complementary medicine treatments for fibromyalgia syndrome. Baillieres Best Pract Res Clin Rheumatol 13 3 (1999) 487-492
61. Logan A.C., and Beaulne T.M. The treatment of small intestinal bacterial overgrowth with enteric-coated peppermint oil: a case report. Altern Med Rev 7 5 (2002) 410-417
62. Pimentel M., et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 63 4 (2004) 450-452
63. Gaby A.R. Intravenous nutrient therapy: the "Myers' cocktail. Altern Med Rev 7 5 (2002) 389-403
64. Yale-Griffin Prevention Research Center, Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia Syndrome: A Pilot Study 2003: NIH, Grant # AT 00942-01A1.
65. Mauskop A., and Altura B.M. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 5 1 (1998) 24-27
66. Mauskop A., et al. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci (Lond) 89 6 (1995) 633-636
67. Lund E., et al. Muscle metabolism in fibromyalgia studied by P-31 magnetic resonance spectroscopy during aerobic and anaerobic exercise. Scand J Rheumatol 32 3 (2003) 138-145
68. Valim V., et al. Aerobic fitness effects in fibromyalgia. J Rheumatol 30 5 (2003) 1060-1069
69. Nampiaparampil D.E., and Shmerling R.H. A review of fibromyalgia. Am J Manag Care 10 11 Pt. 1 (2004) 794-800
70. Gursoy S., et al. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 23 3 (2003) 104-107
71. Yunus M.B., et al. Genetic linkage analysis of multicase families with fibromyalgia syndrome. J Rheumatol 26 2 (1999) 408-412
72. Greenfield S., Fitzcharles M.A., and Esdaile J.M. Reactive fibromyalgia syndrome. Arthritis Rheum 35 6 (1992) 678-681
73. Aaron L.A., et al. Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis Rheum 40 3 (1997) 453-460
74. White K.P., et al. Trauma and fibromyalgia: is there an association and what does it mean?. Semin Arthritis Rheum 29 4 (2000) 200-216
75. Crofford L.J., and Clauw D.J. Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed?. Arthritis Rheum 46 5 (2002) 1136-1138
76. Buskila D., et al. Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 40 3 (1997) 446-452
77. Itoh Y., et al. Immunogenetic background of patients with autoimmune fatigue syndrome. Autoimmunity 32 3 (2000) 193-197
78. Nishikai M., et al. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Rheumatology (Oxford) 40 7 (2001) 806-810
79. Smart P.A., Waylonis G.W., and Hackshaw K.V. Immunologic profile of patients with fibromyalgia. Am J Phys Med Rehabil 76 3 (1997) 231-234
80. Itoh Y., et al. Autoimmune fatigue syndrome and fibromyalgia syndrome. Nippon Ika Daigaku Zasshi 66 4 (1999) 239-244
81. Skowera A., et al. Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients. Clin Exp Immunol 129 2 (2002) 354-358
82. Klein R., Bansch M., and Berg P.A. Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome. Psychoneuroendocrinology 17 6 (1992) 593-598
83. Werle E., et al. Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome. J Rheumatol 28 3 (2001) 595-600
84. Kwiatek R., et al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 43 12 (2000) 2823-2833
85. Mountz J.M., et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38 7 (1995) 926-938
86. Gur A., et al. Regional cerebral blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 20 6 (2002) 753-760
87. Eriksen W. Linking work factors to neck myalgia: the nitric oxide/oxygen ratio hypothesis. Med Hypoth 62 5 (2004) 721-726
88. Lund N., Bengtsson A., and Thorborg P. Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 15 2 (1986) 165-173
89. Henriksson K.G. Chronic muscular pain: aetiology and pathogenesis. Baillieres Clin Rheumatol 8 4 (1994) 703-719
90. Fassbender H.G. Pathology of soft-tissue rheumatism. Med Welt 26 45 (1975) 2036-2038
91. Grassi W., et al. Capillary permeability in fibromyalgia. J Rheumatol 21 7 (1994) 1328-1331
92. Jeschonneck M., et al. Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology (Oxford) 39 8 (2000) 917-921
93. Gronemann S.T., et al. Collagen and muscle pathology in fibromyalgia patients. Rheumatology (Oxford) 43 1 (2004) 27-31
94. Bengtsson A., Henriksson K.G., and Larsson J. Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum 29 7 (1986) 817-821
95. Lindman R., Eriksson A., and Thornell L.E. Fiber type composition of the human female trapezius muscle: enzyme-histochemical characteristics. Am J Anat 190 4 (1991) 385-392
96. Lindman R., et al. Changes in muscle morphology in chronic trapezius myalgia. Scand J Work Environ Health 17 5 (1991) 347-355
97. Larsson S.E., et al. Muscle changes in work-related chronic myalgia. Acta Orthop Scand 59 5 (1988) 552-556
98. Larsson S.E., et al. Chronic trapezius myalgia. Morphology and blood flow studied in 17 patients. Acta Orthop Scand 61 5 (1990) 394-398
99. Larsson S.E., et al. Effects of psychophysiological stress on trapezius muscles blood flow and electromyography during static load. Eur J Appl Physiol Occup Physiol 71 6 (1995) 493-498
100. Sietsema K.E., et al. Oxygen uptake during exercise in patients with primary fibromyalgia syndrome. J Rheumatol 20 5 (1993) 860-865
101. Valim V., et al. Peak oxygen uptake and ventilatory anaerobic threshold in fibromyalgia. J Rheumatol 29 2 (2002) 353-357
102. Acero Jr. C.O., et al. Haemodynamic responses in chronically painful, human trapezius muscle to cold pressor stimulation. Arch Oral Biol 44 10 (1999) 805-812
103. Maekawa K., Clark G.T., and Kuboki T. Intramuscular hypoperfusion, adrenergic receptors, and chronic muscle pain. J Pain 3 4 (2002) 251-260
104. Buskila D., Neumann L., and Press J. Genetic factors in neuromuscular pain. CNS Spectr 10 4 (2005) 281-284
105. Offenbaecher M., et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 42 11 (1999) 2482-2488
106. Elvin A., Siosteen A.K., Nilsson A., and Kosek E. Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: a contrast media enhanced colour Doppler study. Eur J Pain 10 2 (2006) 137-144